RPRD Diagnostics
Amy is a leading scientist with over 10 years of experience in pharmacogenomics and precision medicine translational research. She is responsible for RPRD’s cutting-edge method development and lab operation. Amy is an active participant of the PharmVar Consortium and serves as a Gene Expert Panel member. She leads multiple collaborative projects with academic institutions, healthcare organizations, and drug developers to further all pharmacogenomics applications. Amy’s awareness of technological trends coupled with her extensive insight into the dynamic pharmacogenomics landscape allows her to provide RPRD clients with the most advanced pharmacogenomics consultation available. She received her Master of Science in Pharmacogenomics from Manchester University, Indiana.
This person is not in any offices
RPRD Diagnostics
RPRD (Right Patient Right Drug) Diagnostics specializes in providing innovative pharmacogenomics solutions, including diagnostic, analysis and supporting services to clinicians, researchers and drug developers. With decades of experience in pharmacogenomics research, clinical practice, and healthcare program development, RPRD’s team of experts strives to improve patient lives using pharmacogenomics to enable precision medicine.